Evidence map›Paper›PMID 33425044›Full record

ArticleCognitive computation2021

Pneumonia Classification Using Deep Learning from Chest X-ray Images During COVID-19.

Abdullahi Umar Ibrahim, Mehmet Ozsoz, Sertan Serte, Fadi Al-Turjman, Polycarp Shizawaliyi Yakoi

Open access · hybridAbstract read
In one paragraph

Article in Cognitive computation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
40.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 387 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Abdullahi Umar IbrahimDepartment of Biomedical Engineering, Near East University, Nicosia, Mersin 10, Turkey.ORCID 0000-0003-3850-9921
Mehmet OzsozDepartment of Biomedical Engineering, Near East University, Nicosia, Mersin 10, Turkey.ORCID https://orcid.org/0000-0003-4037-3445
Sertan SerteDepartment of Electrical Engineering, Near East University, Nicosia, Mersin 10, Turkey.
Fadi Al-TurjmanDepartment of Artificial Intelligence, Research Center for AI and IoT, Near East University, Nicosia, Mersin 10, Turkey.
Polycarp Shizawaliyi YakoiDepartment of Computer Engineering, Cyprus International University, Nicosia, Mersin 10, Turkey.
Near East University · CYCyprus International University · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of the novel corona virus disease (COVID-19) in December 2019 has led to global crisis around the world. The disease was declared pandemic by World Health Organization (WHO) on 11th of March 2020. Currently, the outbreak has affected more than 200 countries with more than 37 million confirmed cases and more than 1 million death tolls as of 10 October 2020. Reverse-transcription polymerase chain reaction (RT-PCR) is the standard method for detection of COVID-19 disease, but it has many challenges such as false positives, low sensitivity, expensive, and requires experts to conduct the test. As the number of cases continue to grow, there is a high need for developing a rapid screening method that is accurate, fast, and cheap. Chest X-ray (CXR) scan images can be considered as an alternative or a confirmatory approach as they are fast to obtain and easily accessible. Though the literature reports a number of approaches to classify CXR images and detect the COVID-19 infections, the majority of these approaches can only recognize two classes (e.g., COVID-19 vs. normal). However, there is a need for well-developed models that can classify a wider range of CXR images belonging to the COVID-19 class itself such as the bacterial pneumonia, the non-COVID-19 viral pneumonia, and the normal CXR scans. The current work proposes the use of a deep learning approach based on pretrained AlexNet model for the classification of COVID-19, non-COVID-19 viral pneumonia, bacterial pneumonia, and normal CXR scans obtained from different public databases. The model was trained to perform two-way classification (i.e., COVID-19 vs. normal, bacterial pneumonia vs. normal, non-COVID-19 viral pneumonia vs. normal, and COVID-19 vs. bacterial pneumonia), three-way classification (i.e., COVID-19 vs. bacterial pneumonia vs. normal), and four-way classification (i.e., COVID-19 vs. bacterial pneumonia vs. non-COVID-19 viral pneumonia vs. normal). For non-COVID-19 viral pneumonia and normal (healthy) CXR images, the proposed model achieved 94.43% accuracy, 98.19% sensitivity, and 95.78% specificity. For bacterial pneumonia and normal CXR images, the model achieved 91.43% accuracy, 91.94% sensitivity, and 100% specificity. For COVID-19 pneumonia and normal CXR images, the model achieved 99.16% accuracy, 97.44% sensitivity, and 100% specificity. For classification CXR images of COVID-19 pneumonia and non-COVID-19 viral pneumonia, the model achieved 99.62% accuracy, 90.63% sensitivity, and 99.89% specificity. For the three-way classification, the model achieved 94.00% accuracy, 91.30% sensitivity, and 84.78%. Finally, for the four-way classification, the model achieved an accuracy of 93.42%, sensitivity of 89.18%, and specificity of 98.92%.

Indexed as

AlexNetBacterial pneumoniaChest X-rays images (CXR)COVID-19Non-COVID-19 viral pneumonia

Identifiers

PMID33425044
PMCPMC7781428
OpenAlexW3120327591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.